The Latest Breaking News from IDEXX Laboratories

Upgrades

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 9.28%. Currently, IDEXX Laboratories has a market capitalization of $30.26 billion.

Upgrades

  IDEXX Laboratories (NASDAQ:IDXX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

IDEXX Laboratories (NASDAQ:IDXX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that IDEXX Laboratories will report an earnings per share (EPS) of $2.26.

  IDEXX Laboratories (NASDAQ:IDXX) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results.

Given the unprecedented increase in pet ownership since the onset of the COVID-19 pandemic, rising consumer spending on pet food, medications, and other ancillary pet services has driven the pet care industry’s growth. Because high demand is expected to persist going forward, prominent pet stocks IDEXX Laboratories (IDXX) and Elanco…

IDEXX Laboratories Inc (NASDAQ: IDXX) reported 

  IDEXX Laboratories (NASDAQ:IDXX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.